Le Lézard
Classified in: Health, Science and technology, Covid-19 virus

Redrock Biometrics is Waiving the Licensing Fee of Its PalmID® Software


SAN FRANCISCO, March 30, 2020 /PRNewswire/ -- Redrock Biometrics, a leading provider of palm-based biometrics for authentication and identification, announced it will wave its PalmID® license fee to businesses that are labeled as essential during this pandemic for one year or longer in order to help prevent spread the COVID-19. "We would like to play our part in helping our community in this fight," says Redrock biometrics co-founder Lenny Kontsevich.

Using a standard RGB camera and/or infrared camera, PalmID® captures palm prints and/or subdermal veins to produce a highly unique palm signature. Proprietary PalmID® algorithms match palm signatures for a wide range of palm positions, orientations, and illumination conditions. The SaaS component of PalmID® is capable to perform matching of a newly captured palm signature with tens of thousands of signatures stored in its database in a fraction of a second.

"COVID-19 quarantine made us acutely aware that touching devices represents a threat to our lives. People become touch-phobic and their faces are covered by masks, which creates a need for a touchless palm solution. With PalmID®, simply hold your hand in front of a reader," says Kontsevich.

Redrock Biometrics (www.redrockbiometrics.com) is a creator of PalmID® technology for matching palm images captured in visible and infrared spectra. The company is located in San Francisco.

CONTACT INFORMATION
RedRock Biometrics
Contact Name: Sergei Badeka
(m) 650.766.8473
(e) [email protected]

Related Images

palmid-logo.png
PalmID Logo
PalmID Logo

SOURCE RedRock Biometrics


These press releases may also interest you

at 18:56
Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:...

at 18:30
Striking Teamsters at pharmaceutical giant Cencora (formerly known as AmerisourceBergen) rallied today outside the company's Sacramento distribution center. The 124 warehouse workers are members of Teamsters Local 150 and have been on strike since...

at 18:00
Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announced a research collaboration with Dr. Jessica M. Konen's Lab at Emory University School of Medicine....

at 17:58
More than 200 workers at American Medical Response (AMR) in Springfield and Greenfield have voted overwhelmingly to join Teamsters Local 404....

at 17:54
The American Association of Kidney Patients (AAKP), the largest and oldest independent kidney patient organization in the nation, is celebrating National Doctors Day by highlighting three top kidney medical experts and authors known for their...

at 17:20
Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced it granted an inducement award on March 28, 2024. One individual was...



News published on and distributed by: